GlassScriptPhysician profile
Joseph Patrick Riley
NPI 1881668911
$348.78
in general payments reported to CMS, 2019-2025
12 companies · $61.96 in 2025
The $61.96 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.00 · 2020: $27.96 · 2021: $111 · 2022: $122 · 2024: $13.40 · 2025: $61.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $80.23 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $66.89 | 2021-2022 | |
| Ethicon US, LLC | $36.41 | 2025 | Stratafix, Surgicel Nu-Knit |
| Merck Sharp & Dohme LLC | $28.46 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.98 | 2019-2020 | |
| Minerva Surgical, INC | $25.55 | 2025 | |
| Novo Nordisk INC | $17.49 | 2022 | |
| Biogen, INC. | $15.99 | 2021 | |
| Organon LLC | $14.81 | 2022 | |
| Exact Sciences Corporation | $13.40 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $12.08 | 2021 | |
| Lilly USA, LLC | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.